Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 10/20/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Array BioPharma Inc, Boulder, CO Bristol Myers Squibb Merck & Co., Inc. Nektar Therapeutics |
None | None | None | ✔ |
| Christopher Barker MD | Alpha Tau Medical Amgen Inc. Elekta EMD Serono Merck & Co., Inc. Physical Sciences Incorporated (through subcontracted funds from NIH) Regeneron Pharmactcls |
None | None | None | ✔ |
| Sarah Bateni MD, MAS | None | None | None | None | ✔ |
| Joel Baumgartner MD | None | None | None | None | ✔ |
| Shailender Bhatia MD | EMD Serono | Bristol Myers Squibb Incyte Corporation |
None | None | ✔ |
| Christopher Bichakjian MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Nicole Blankenhorn | None | None | None | None | - |
| Genevieve Boland MD, PhD | InterVenn Biosciences Olink Proteomics Palleon Pharmaceuticals Takeda Pharmaceuticals North America, Inc. Teiko |
Ankyra Therapeutics InterVenn Biosciences Iovance pharmaceuticals Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation |
None | Ankyra | - |
| Sunandana Chandra MD, MS | None | Bristol Myers Squibb Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmactcls |
None | None | ✔ |
| Bartosz Chmielowski MD, PhD | Adagene Advenchen Laboratories Ascentage Atreca Bristol Myers Squibb Compugen Delcath IDEAYA Biosciences Immunocore Infinity Pharmaceuticals, Inc InstilBio Karyopharm Therapeutics Kezar Life Sciences Kinnate Macrogenics Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation PACT Pharma RAPT Therapeutics Replimune Trisalus Xencor Xilio |
Atreca Expert Witness Replimune |
None | None | ✔ |
| Dominick DiMaio MD | None | None | None | None | ✔ |
| Roxana Dronca MD | Alkermes Bristol Myers Squibb Emerson Collective Phosplatin Therapeutics Regeneron Pharmactcls Sorento Therapeutics |
Bristol Myers Squibb Eisai Inc. Elsevier, Inc. |
Bristol Myers Squibb Eisai Inc. Elsevier, Inc. |
None | ✔ |
| Sara Espinosa PhD | None | None | None | None | - |
| Ryan Fields MD | None | None | None | None | ✔ |
| Martin Fleming MD, FACS | None | None | None | None | ✔ |
| Anjela Galan MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Samantha Guild JD | None | Melanoma Research Program (CDMRP) State of Texas |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Laura Hanisch PsyD | None | None | None | None | - |
| Erin Hesler | None | None | None | None | - |
| John Hyngstrom MD | Amgen Inc. Bristol Myers Squibb Checkmate Iovance pharmaceuticals Lokon Lyell Merck & Co., Inc. Morphogenesis Naterra National Cancer Institute Oncosec Philogen SkylineDX |
None | None | None | ✔ |
| Douglas Johnson MD, MSCI | None | Bristol Myers Squibb Merck & Co., Inc. Pfizer Inc. Teiko |
None | Patent for MHC-II as a biomarker for immunotherapy response|Patient for abatacept or belatacept as treatment for refractory irAEs | ✔ |
| Madeline Joyce BSN, RN, OCN | None | None | None | None | - |
| Giorgos Karakousis MD | Merck & Co., Inc. | Merck & Co., Inc. | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Kari Kendra MD, PhD | Bristol Myers Squibb checkmate pharmaceuticals GSK Immunocore medspace Merck & Co., Inc. National Institute on Aging Regeneron Pharmaceuticals, Inc. Varian Medical Systems |
None | None | None | ✔ |
| Maija Kiuru MD, PhD | CalDerm NanoString Technologies, Inc. National Institute of Arthritis and Musculoskeletal and Skin Diseases NCI NIH UC Davis |
None | None | None | ✔ |
| Julie Lange MD, ScM | None | None | None | None | ✔ |
| Ryan Lanning MD, PhD | None | None | None | None | ✔ |
| Theodore Logan MD, FACP | Abbott Laboratories Abraxis Bioscience, Inc. Acceleron Pharma, Inc. Amgen Inc. Argos Therapeutics AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. Bristol Myers Squibb Cerulean Pharma Dynavax Technologies Eisai Inc. Eli Lilly and Company EMD Serono GSK Immatics Iovance pharmaceuticals MacroGenics MedImmune Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. NiKang Therapeutics Novartis Pharmaceuticals Corporation Peloton Therapeutics, Inc. Pfizer Inc. Prometheus Roche Laboratories, Inc. sanofi-aventis U.S. Synta Pharmaceuticals Corp. Threshold Pharmaceuticals TRACON Pharmaceuticals, Inc. |
None | None | None | ✔ |
| Miguel Materin MD | None | AstraZeneca Pharmaceuticals LP Castle Biosciences Ideaya Biosciences |
None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Daniel Olson MD | Astellas Pharma US, Inc. Bayer HealthCare Immunocore Inhibrix Iovance pharmaceuticals |
Alphinsights GLG Consulting Iovance pharmaceuticals Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Anthony Olszanski MD, RPh | Alkermes Astellas Pharma US, Inc. Bristol Myers Squibb Checkmate Eutilex F-Star Glyconex GSK InstilBio Intensity Istari Kadmon Kartos Kezar Kinnate OncoSec Pfizer Inc. Regeneron Pharmactcls Sumitomo Dainippon Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb Eisai Inc. InstilBio Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Patrick Ott MD, PhD | Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. Oncorus Xencor |
Bristol Myers Squibb Evaxion Merck & Co., Inc. Pfizer Inc. Phio |
None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Merrick Ross MD | Amgen Inc. | Amgen Inc. Merck & Co., Inc. |
None | None | ✔ |
| Luke Rothermel MD, MPH | None | None | None | None | ✔ |
| April Salama MD | Ascentage Bristol Myers Squibb Ideaya Immunocore Merck & Co., Inc. Olatec Regeneron Pharmactcls Replimune SeaGen |
Bristol Myers Squibb Iovance pharmaceuticals Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmaceuticals, Inc. Replimune |
None | None | ✔ |
| Rohit Sharma MD | None | None | None | None | - |
| Arun Singh MD | Castle Bisosciences | AURA ISOAID LLC |
Immunocore | AURA | - |
| Joseph Skitzki MD | None | None | None | None | - |
| Andrew Stacey MD, MS | None | None | None | None | - |
| Susan Swetter MD | None | None | None | None | ✔ |
| Katy Tsai MD | ABM Therapeutics AstraZeneca Pharmaceuticals LP BioAtla Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec OnKure Pfizer Inc. Replimune |
None | None | None | - |
| Evan Wuthrick MD | None | MyCareGorithm Teiko |
None | None | - |
| Yan Xing MD, PhD | None | None | None | None | ✔ |